Aronora has big plans for its cardiovascular drugs Posted on January 14, 2021 by Administrator in References Erik Tucker, Aronora’s COO, stands in the biotech company’s new space, which is being prepared for a February move-in. The buildout was funded in part with Oregon State Lottery funds administered by the Oregon Business Development Dept. View Post Cardiovascular Biotech, Cardiovascular Drugs, Oregon Biotech, Portland Biotechnology, Portland Tech Sector
